Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 192

Results For "RTS"

2543 News Found

New report highlights lack of access to assistive technology
Healthcare | May 16, 2022

New report highlights lack of access to assistive technology

WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products


CCMB develops India’s first mRNA vaccine technology
News | May 14, 2022

CCMB develops India’s first mRNA vaccine technology

The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere


Ultivue announces AI Partner Ecosystem to accelerate research in translational medicine
Biotech | May 13, 2022

Ultivue announces AI Partner Ecosystem to accelerate research in translational medicine

Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation


All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week
News | May 13, 2022

All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week

As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year


GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech
Medical Device | May 12, 2022

GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech

GenNext and Kiko Tech will provide sales and marketing, customer service, technical support, training, and related logistical efforts for Flash Oxidation Protein Footprinting Systems.


Philips expands manufacturing and research facility in Pune, Maharashtra
News | May 12, 2022

Philips expands manufacturing and research facility in Pune, Maharashtra

The company exports mobile surgery equipment to over 100 countries from Pune


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19


Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform
Biotech | May 12, 2022

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform

The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams


Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY
News | May 10, 2022

Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY

The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt